Stefan Draeger - Drgerwerk Chairman of the Executive Board, CEO
| DRWKFDelisted Stock | USD 44.66 0.00 0.00% |
Chairman
Mr. Stefan Draeger was Chairman of the Executive Board and Chief Executive Officer of Draegerwerk AG Co. KGaA since March 1, 2005. He was Member of the Executive Board since January 1, 2003. Mr. Draeger joined the Company in 1992. Following this he served at Company branches in Germany, Canada and the USA. In 1995 he served as Head of Product Management at the Company. From 1999 to 2002, he was Head of the Intensive Care Business Unit. Since July, 2005, he was acting as Chief Executive Officer of Draeger Medical AG Co. KG since March 2004 as Deputy Chairman of the Executive Board at Draegerwerk AG and since March 2003 as Member of Executive Board for Corporationrationrate Functions at Draegerwerk AG. Since April 27, 2010 he has acted as Member of the Supervisory Board of Sparkasse zu Luebeck, Chairman of the Executive Board of Dragerwerk Verwaltungs AG, Chairman of the Executive Board of Drager Safety Verwaltungs AG, Lubeck and Managing Director of Drager Medical GmbH, Lubeck, until August 2, 2015. He graduated from Berufsakademie Stuttgart and holds a Dipl.Ing. degree in Electrical Engineering. He also attended integrated degree program in electrical engineering in cooperation with HewlettPackard in Boeblingen, Germany. since 2005.
| Age | 54 |
| Tenure | 19 years |
| Phone | 49 451 882 3202 |
| Web | https://www.draeger.com |
Drgerwerk Management Efficiency
The company has return on total asset (ROA) of (0.0274) % which means that it has lost $0.0274 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1002) %, meaning that it generated substantial loss on money invested by shareholders. Drgerwerk's management efficiency ratios could be used to measure how well Drgerwerk manages its routine affairs as well as how well it operates its assets and liabilities.The company has accumulated 184.84 M in total debt with debt to equity ratio (D/E) of 0.25, which may suggest the company is not taking enough advantage from borrowing. Drgerwerk AG has a current ratio of 1.71, which is within standard range for the sector. Debt can assist Drgerwerk until it has trouble settling it off, either with new capital or with free cash flow. So, Drgerwerk's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Drgerwerk AG sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Drgerwerk to invest in growth at high rates of return. When we think about Drgerwerk's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 5 records | CHAIRMAN Age | ||
| Don Hankey | Bone Biologics Corp | N/A | |
| William Stern | NanoVibronix | 71 | |
| Bruce Stroever | Bone Biologics Corp | 66 | |
| Dan Gladney | ReShape Lifesciences | 71 | |
| Christopher Fashek | NanoVibronix | N/A | |
Management Performance
| Return On Equity | -0.1 | |||
| Return On Asset | -0.0274 |
Drgerwerk AG Leadership Team
Elected by the shareholders, the Drgerwerk's board of directors comprises two types of representatives: Drgerwerk inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Drgerwerk. The board's role is to monitor Drgerwerk's management team and ensure that shareholders' interests are well served. Drgerwerk's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Drgerwerk's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Reiner Piske, Executive Board member for Human Resources Regional responsibility for Europe | ||
| Thomas Fischler, Head Relations | ||
| Welf Bttcher, Head Communications | ||
| Walter Neundorf, Member of the Supervisory Board | ||
| Stefan Draeger, Chairman of the Executive Board, CEO | ||
| Klaus Rauscher, Member of the Supervisory Board | ||
| Reinhard Zinkann, Member of the Supervisory Board, Employee Representative | ||
| Anton Schrofner, Member of Executive Board of Drägerwerk Verwaltungs AG | ||
| Bettina Almsick, Member of the Supervisory Board | ||
| Siegfrid Kasang, Vice Chairman of the Supervisory Board, Employee Representative | ||
| KlausDieter Fett, Member of the Supervisory Board, Employee Representative | ||
| Daniel Friedrich, Member of the Supervisory Board | ||
| Stefan Lauer, Member of the Supervisory Board | ||
| Nikolaus Schweickart, Chairman of the Supervisory Board, Employee Representative | ||
| Ulrike Tinnefeld, Member of the Supervisory Board, Employee Representative | ||
| Nike Benten, Member of the Supervisory Board | ||
| Stefan BA, Chairman AG | ||
| Uwe Lueders, Member of the Supervisory Board | ||
| Thorsten Grenz, Member of the Supervisory Board | ||
| Thomas Rickers, Member of the Supervisory Board, Employee Representative | ||
| Stefan Klein, Member of the Supervisory Board | ||
| Stephan Kruse, Medical Therapy | ||
| Rainer Klug, Member of the Executive Board, Chief Supply Chain Officer | ||
| GertHartwig Lescow, CFO, Member of the Executive Board |
Drgerwerk Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Drgerwerk a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.1 | |||
| Return On Asset | -0.0274 | |||
| Profit Margin | (0.04) % | |||
| Operating Margin | (0.05) % | |||
| Current Valuation | 785.39 M | |||
| Shares Outstanding | 8.6 M | |||
| Shares Owned By Institutions | 29.18 % | |||
| Price To Earning | 3.71 X | |||
| Price To Book | 0.51 X | |||
| Price To Sales | 0.26 X |
Pair Trading with Drgerwerk
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Drgerwerk position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Drgerwerk will appreciate offsetting losses from the drop in the long position's value.Moving against Drgerwerk OTC Stock
| 1.0 | EPGG | Empire Global Gaming | PairCorr |
The ability to find closely correlated positions to Drgerwerk could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Drgerwerk when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Drgerwerk - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Drgerwerk AG Co to buy it.
The correlation of Drgerwerk is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Drgerwerk moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Drgerwerk AG moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Drgerwerk can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in industry. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Consideration for investing in Drgerwerk OTC Stock
If you are still planning to invest in Drgerwerk AG check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Drgerwerk's history and understand the potential risks before investing.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Stocks Directory Find actively traded stocks across global markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |